2012
DOI: 10.1182/blood-2012-04-420828
|View full text |Cite
|
Sign up to set email alerts
|

MKL1 and MKL2 play redundant and crucial roles in megakaryocyte maturation and platelet formation

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

2
76
0

Year Published

2014
2014
2022
2022

Publication Types

Select...
5
2
1

Relationship

0
8

Authors

Journals

citations
Cited by 54 publications
(78 citation statements)
references
References 46 publications
2
76
0
Order By: Relevance
“…In agreement, knocking down either MYOCD or MRTF-A and -B decreased CDH11-mediated expression of collagen and elastin, but the effects of MRTF-A and -B were significantly stronger. Although past studies have only recognized MRTF and MYOCD as co-activators of SRF, some recent studies have shown that they can act as transcription factors independently (Tang et al, 2008;Asparuhova et al, 2011;Luchsinger et al, 2011;Smith et al, 2012;Kitchen et al, 2013). MRTF-A has been shown to control Col1A2 promoter activity as well as expression of other extracellular matrix molecules (Asparuhova et al, 2011;Luchsinger et al, 2011).…”
Section: Discussionmentioning
confidence: 99%
“…In agreement, knocking down either MYOCD or MRTF-A and -B decreased CDH11-mediated expression of collagen and elastin, but the effects of MRTF-A and -B were significantly stronger. Although past studies have only recognized MRTF and MYOCD as co-activators of SRF, some recent studies have shown that they can act as transcription factors independently (Tang et al, 2008;Asparuhova et al, 2011;Luchsinger et al, 2011;Smith et al, 2012;Kitchen et al, 2013). MRTF-A has been shown to control Col1A2 promoter activity as well as expression of other extracellular matrix molecules (Asparuhova et al, 2011;Luchsinger et al, 2011).…”
Section: Discussionmentioning
confidence: 99%
“…[30][31][32] Recently, the first case of a homozygous mutation in MKL1 in a patient with severe immunodeficiency and no hematologic malignancies was reported. 33 One interesting phenotypic presentation of the affected individual was an intermittent mild thrombocytopenia with low platelet counts in whole blood of between 50x10 9 /L and 150x10 9 /L.…”
Section: Family Patient Gene(s) Genomic Variation Protein Effect Varimentioning
confidence: 99%
“…However specific deletion of Srf in the MK compartment using a PF4-Cre system leads to macrothrombocytopenia with accumulation of abnormal low ploidy early MK progenitors. Mkl1 knockout mice also display thrombocytopenia [160,163] although with a phenotype that is less severe than the one observed in Srf knockout mice, probably relating to a compensating role of Mkl2 [164].…”
Section: Srf and Mkl1mentioning
confidence: 99%